Goldline Pharmaceuticals is engaged in the marketing and distribution of pharmaceutical products under the “Goldline” brand. The company’s portfolio is categorised into five divisions, namely Goldline Pharma, Goldline Cardinal, Goldline Aayushman, Goldline InLife, and Goldline Wellness. These divisions cater to multiple therapeutic segments including cardiology, diabetology, orthopaedics, paediatrics, neurology, gastroenterology, critical care, and supportive cancer care. As per the company information, the portfolio consists of more than 140 products designed for different medical specialities and healthcare requirements. The company follows an asset-light operating model where medicines are manufactured through third-party manufacturing partners based on its product specifications and market requirements.
The company markets and distributes its products through a network of distributors supplying retailers and wholesalers across multiple states including Maharashtra, Madhya Pradesh, Odisha, Jharkhand, Tamil Nadu, Rajasthan, and Bihar. Goldline Pharmaceuticals currently works with 15 manufacturing partners and 7 distributors for its operations. In addition to product marketing, the company also supports hospitals and healthcare institutions with procurement and material supply services. Its business model is focused on product branding, distribution management, and therapeutic expansion across selected domestic markets while ensuring regulatory compliance and quality standards through third-party manufacturing arrangements.